促红细胞生成素在新生儿缺氧缺血性脑病中的应用效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application effect of Erythropoietin （EPO） on neonatal hypoxic-ischemic encephalopathy (HIE).Methods A total of 80 patients HIE with EPO treated in our hospital from March 2016 to September 2018 were selected and divided into control group and observation group by random number table method,40 cases in each group.The control group was given conventional treatment,and the observation group was given EPO treatment on the basis of the control group.After treatment,the therapeutic effect,the newborn′s neurobehavioral development,intellectual development and birth quality between the two groups were compared. Results The total effective rate in the observation group was 95.00% (38/40),higher than that of the control group,accounting for 77.50% (31/40),and the difference was statistically significant (P=0.023).The 2 and 4 week neonatal behavioral neurological assessment(NBNA) scores in the observation group were higher than those of the control group,and the differences were statistically significant (P<0.05).At 3 and 6 months after birth,the psychological development index (PDI) score and mental development index (MDI) score of the observation group were higher than those of the control group,and the differences were statistically significant (P<0.05).After the age of 10 months,the scores of psychomotor function area,gross motor function area,language function area,social adaption function area,and personal social contact function area in the observation group were higher than those of the control group,the differences were statistically significant (P<0.05).Conclusion The use of EPO treatment for HIE is beneficial to promoting the recovery of neurological function,ameliorating intellectual development,and improving birth quality.It is worthy of clinical promotion.

Key words： Hypoxic-ischemic encephalopathy Erythropoietin Neurological function Newborn Birth quality

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FENG Yan

Cite this article:

FENG Yan. Application effect of Erythropoietin on neonatal hypoxic-ischemic encephalopathy[J]. 中国当代医药, 2020, 27(21): 116-118.

URL:

https://dangdaiyiyao.com/EN/ OR https://dangdaiyiyao.com/EN/Y2020/V27/I21/116

[1]	杨青美.综合疗程治疗干预对新生儿缺血缺氧性脑病的康复影响[J].川北医学院学报，2016，31（3）：373-376.
[2]	宋柳全，黄夏，陈燕鸿，等.脑苷肌肽注射液对新生儿缺氧缺血性脑病血清IL-1β 与NBNA 评分的影响及成本分析[J].解放军预防医学杂志，2019，37（6）：122-123，125.
[3]	张建宁.NGF 联合胞二磷胆碱＋脑蛋白水解物对新生儿缺氧缺血性脑病神经行为发育及血清指标的影响[J].海南医学院学报，2016，22（19）：2325-2328.
[4]	赵宏，霍晓慧，裴怀腾.高压氧治疗对新生儿缺氧缺血性脑病氧化应激状态及脑血流的影响[J].实用临床医药杂志，2016，20（17）：85-87.
[5]	章樱，陈国庆，张勤.磷酸肌酸钠对新生儿缺氧缺血性脑病氧化应激的影响及心肌损伤的保护作用[J].中华全科医学，2016，14（5）：786-789.
[6]	中华医学会儿科学分会新生儿学组.新生儿缺氧缺血性脑病诊断标准[J].中国当代儿科杂志，2005，7（2）：97-98.
[7]	朱静，张楠，刘立娟，等.促红细胞生成素治疗新生儿缺氧缺血性脑病的疗效观察[J].山东大学学报（医学版），2016，54（4）：60-63.
[8]	黄健，唐晓霞.亚低温联合促红细胞生成素治疗新生儿缺氧缺血性脑病疗效观察[J].海南医学，2017，28（22）：3728-3729.
[9]	钱丹，姜勇超等.促红细胞生成素配合单唾液酸四己糖神经节苷脂治疗新生儿缺氧缺血性脑病效果分析[J].中国综合临床，2016，32（3）：272-275.
[10]	尚云，夏于荣，郭喜霞，等.促红细胞生成素与亚低温治疗在足月新生儿缺氧缺血性脑病中的疗效对比[J].河北医学，2019，25（2）：292-296.
[11]	裴雪梅，高然，张国英，等.促红细胞生成素对新生儿缺氧缺血性脑病患儿血清NSE 和S-100B 的影响[J].中国当代儿科杂志，2014，16（7）：705-708.
[12]	曾庆煌，曾仁和.重组人促红细胞生成素联合外源性单唾液酸四己糖神经节苷脂治疗重度新生儿缺氧缺血性脑病的疗效[J].中华实用儿科临床杂志，2016，31（20）：1582-1583.
[13]	廖钊，胡晓，王建怡.促红细胞生成素神经保护作用的研究进展[J].中风与神经疾病杂志，2014，31（5）：472-474.
[14]	杨爱香.早期不同时间窗干预对新生儿缺氧缺血性脑病预后影响的研究[J].河北医学，2016，22（9）：1516-1518.
[15]	杜京辉.重组人促红细胞生成素辅助治疗新生儿缺氧缺血性脑病疗效观察[J].山东医药，2015，55（38）：70-71.